YC LogoYC Logo
Back arrow
back

Y Combinator Funds Illuminant Surgical in S22 Batch

September 30, 2022

Illuminant Surgical has been selected to participate in Y Combinator's S22 Batch. 

For the Summer 2022 batch, YC received 19,000 applications from founders around the world and funded 240. Additionally, only 9% of the batch are healthcare companies. We will present to an invite-only audience of investors at YC's 35th Demo Day.

We are excited to work with our partners at YC to help bring our product to patients!

Illuminant overhead equipmentIlluminant overhead equipment

Illuminant allows you to see everything you need to deliver the highest-quality surgical procedures all in one place, in real time.

Our Technology

Similar Articles

Events

Illuminant Displays Technology at COMPUTEX Taipei

As part of Illuminant’s acceptance into the Garage+ Start-up Global Program, founders James Hu and Eldrick Millares traveled to Taipei, Taiwan to showcase Illuminant’s technology to the global community at COMPUTEX 2023.

Publications

Illuminant Presents at CNS 2023

The Illuminant team had the opportunity to present two projects at the CNS 2023 Annual Meeting in Washington, D.C.

News

Illuminant Awarded Federal Grant from National Science Foundation

We are excited to announce that we have been awarded a federal grant from the National Science Foundation (NSF). This non-dilutive Phase 1 grant will provide funding to further develop and validate our technology’s application in spine surgery.

Contact Us

Reach out to us to get a closer look at the future of surgical navigation

founders@illuminant.ai
5855 Green Valley Circle
Culver City, CA
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
© 2023 Illuminant. All rights reserved.
Privacy PolicyTerms of Service

The Illuminant Surgical Navigation System is being designed with the intent to improve surgery. All information on this website represents the design goals of Illuminant Surgical and has not been evaluated by the United States Food and Drug Administration (FDA). The product has not been cleared by the FDA and is not for commercial sale in the United States.